Fall from 'Best Places to Work' - IT Manager bei Genentech: Mitarbeiterbewertung

3,0
13. Nov. 2012
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

+ Fully integrated biotech, meaning that you can move between jobs in sales, research, development, manufacturing and in support functions -- all in the same company + Promising drug pipeline

Kontras

Many of the perqs that were omnipresent during the Avastin years are slowly dropping away, as Roche takes a firmer hand managing the compensation of the US (Genentech) staff. This is least apparent in Research; most apparent in the support functions (IT, HR, Legal, etc.). Be very wary of putting too much stock in the 'Best Places to Work' wins in 2008-2011 -- much has changed since then.

Mehr Bewertungen zu Genentech entdecken

5,0
27. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Patient-centric company. great culture & benefits

Kontras

Not always clear how promotions are awarded.

2,0
19. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

The work is meaningful and overall the company vision aligns with my goals

Kontras

QA management has become inept. None of the leadership (aside from maybe one or two) truly understand the nuances of our site and jobs. They refuse to pay you more due to "budget" reasons but won't provide much information, they claim to be transparent but will make decisions behind your back and not communicate them, even if they impact you and/or your job. Leadership doesn't listen to feedback and gets defensive if you even try to give any. It honestly has become a game of politics only in QA and that's not really building any real quality culture.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle